Eberhard Heymann
Impact in
- Pharmacology top 1%
- Cholinesterase and Neurodegenerative Diseases
- Pharmacogenetics and Drug Metabolism
- Oncology top 5%
- Peptidase Inhibition and Analysis
- Drug Transport and Resistance Mechanisms
Papers in
- Pharmacology 27
- Cholinesterase and Neurodegenerative Diseases 26
- Pharmacogenetics and Drug Metabolism 4
-
- Computational Drug Discovery Methods 13
- Co-authors
- Rolf MentleinK KrischWolfgang JungeAlfred C. FellerWilhelm P. NeumannMeinolf SuttorpErnst BrandtWolfgang Scholz
- Journals
- European Journal of Biochemistry (7 papers)Archives of Biochemistry and Biophysics (6 papers)Biochemical Pharmacology (5 papers)FEBS Letters (3 papers)Biochemical Journal (3 papers)
- Partner nations
- GermanyUnited StatesNorway
In The Last Decade
Eberhard Heymann
64 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 115
- Pharmacology 690
- Oncology 729
- Pharmacology 231
- Cellular and Molecular Neuroscience 451
- Computational Theory and Mathematics 370
Countries citing papers authored by Eberhard Heymann
This map shows the geographic impact of Eberhard Heymann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eberhard Heymann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eberhard Heymann more than expected).
Fields of papers citing papers by Eberhard Heymann
This network shows the impact of papers produced by Eberhard Heymann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eberhard Heymann. The network helps show where Eberhard Heymann may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Eberhard Heymann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 1 | |
| 2 | 1996 | 39 | |
| 3 | 1993 | 17 | |
| 4 | 1990 | 75 | |
| 5 | 1990 | 106 | |
| 6 | 1988 | 57 | |
| 7 | 1985 | 63 | |
| 8 | 1984 | 88 | |
| 9 | 1981 | 60 | |
| 10 | 1980 | 4 | |
| 11 | 1979 | 71 | |
| 12 | [An investigation of the microheterogeneity and the subunit structure of carboxylestereases by the quanititative determination of the terminal amino acids]. | 1974 | 4 |
| 13 | 1971 | 20 | |
| 14 | 1969 | 65 | |
| 15 | [Phosphoric acid-bis-(p-nitro-phenylester), a new inhibitor of microsomal carboxylesterases]. | 1967 | 41 |
| 16 | 1964 | 48 | |
| 17 | 1963 | 28 | |
| 18 | 1963 | 3 | |
| 19 | 1963 | 42 | |
| 20 | 1963 | 19 |
About Eberhard Heymann
Eberhard Heymann is a scholar working on Pharmacology, Computational Theory and Mathematics, Oncology, Molecular Biology and Biochemistry, having authored 65 papers that have together received 2.4k indexed citations. Recurring topics across this work include Cholinesterase and Neurodegenerative Diseases (26 papers), Enzyme function and inhibition (19 papers), Peptidase Inhibition and Analysis (15 papers), Computational Drug Discovery Methods (13 papers), Neuropeptides and Animal Physiology (8 papers), Chemical Synthesis and Analysis (7 papers), Enzyme Catalysis and Immobilization (6 papers) and Pharmacogenetics and Drug Metabolism (4 papers). The work is most often cited by research in Pharmacology (690 citations), Oncology (729 citations), Pharmacology (231 citations), Cellular and Molecular Neuroscience (451 citations) and Computational Theory and Mathematics (370 citations). Eberhard Heymann has collaborated with scholars based in Germany, United States and Norway. Frequent co-authors include Rolf Mentlein, K Krisch, Wolfgang Junge, Alfred C. Feller, Wilhelm P. Neumann, Meinolf Suttorp, Ernst Brandt, Wolfgang Scholz, A.J. Ulmer and O. v. Deimling. Their work appears in journals such as European Journal of Biochemistry, Archives of Biochemistry and Biophysics, Biochemical Pharmacology, FEBS Letters and Biochemical Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.